← 產業報告目錄
Cervical Spondylosis Diagnosis & Treatment Market Size, Share & Trends Analysis Report By Diagnosis (Imaging Tests, Neck X-ray, MRI, CT Myelography, Nerve Function Tests, Electromyography, Nerve Conduction Study), By Product Type (Medications, Medical Devices, Surgical Instruments), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And By Segment Forecasts, 2024-2031.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-18頁數 179報告編號 INSIGHTACE-2b26b8bb24
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the Cervical Spondylosis Diagnosis & Treatment Market worldwide was assessed at USD 6.19 Bn. Analysts project it will expand to USD 10.14 Bn by 2031, at a CAGR of 6.3% spanning 2024 to 2031.
At its core, Cervical Spondylosis Diagnosis & Treatment pertains to a degenerative disorder that affects the neck region and is treated with therapy. Stakeholders across the healthcare landscape are risingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cervical Spondylosis Diagnosis & Treatment Market Snapshot
Chapter 4. Global Cervical Spondylosis Diagnosis & Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Diagnosis Estimates & Trend Analysis
5.1. by Diagnosis & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Diagnosis:
5.2.1. Imaging Tests
5.2.2. Neck X-ray
5.2.3. MRI
5.2.4. CT Myelography
5.2.5. Nerve Function Tests
5.2.6. Electromyography
5.2.7. Nerve Conduction Study
Chapter 6. Market Segmentation 2: by Product Type Estimates & Trend Analysis
6.1. by Product Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
6.2.1. Medications
6.2.1.1. Non-steroidal AntiInflammatory Drugs
6.2.1.2. Muscle Relaxants
6.2.1.3. Antidepressants
6.2.1.4. Pain Relievers
6.2.2. Medical Devices
6.2.2.1. Cervical Collars
6.2.2.2. Neck Traction Devices
6.2.2.3. TENS Units
6.2.2.4. Cervical Pillows
6.2.3. Surgical Instruments
6.2.3.1. Spinal Implants
6.2.3.2. Other Surgical Instruments
Chapter 7. Market Segmentation 3: by Distribution Channel Estimates & Trend Analysis
7.1. by Distribution Channel & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Cervical Spondylosis Diagnosis & Treatment Market Segmentation 6: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.1.2. North America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.1.3. North America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.1.4. North America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.2.2. Europe Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.2.3. Europe Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.2.4. Europe Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.3.2. Asia Pacific Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.3.3. Asia-Pacific Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.3.4. Asia Pacific Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.4.2. Latin America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.4.3. Latin America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.4.4. Latin America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.5.2. Middle East & Africa Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.5.3. Middle East & Africa Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.5.4. Middle East & Africa Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Novartis AG
9.2.2. Merck & Co. Inc.
9.2.3. Bayer AG
9.2.4. Abbott
9.2.5. Ortho Bracing
9.2.6. Medtronic
9.2.7. Stryker Corporation
9.2.8. B. Braun Medical Ltd.
9.2.9. DJO, LLC
9.2.10. Aspen Medical Products, LLC
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們